Riikka Kivelä

NAD+ precursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeria

Summary Nicotinamide adenine dinucleotide (NAD + ) plays a central role in energy metabolism, and its decline is linked to various degenerative diseases. While NAD + restoration holds therapeutic promise, its long term, tissue-specific consequences remain poorly understood. We in...